What does today’s Supreme Court decision to overturn gene patents mean for you?
This is a true victory for women’s health. And we know there are a lot of questions about the details of the ruling: What does this mean for research and second opinions? What is the distinction between patents on DNA vs. cDNA? Are ALL patents on human genes now a thing of the past?
Join me and our outstanding panel of experts on June 25th at 11am PDT/2pm EDT for an interactive conversation about the far-reaching impact of the Supreme Court’s decision for patients, research, treatment and the future of gene patents for women living with and at risk of breast cancer.
I’ll be joined on this call by a terrific group of experts who will be able to answer all your questions about this landmark ruling:
- Roger Klein, Molecular Pathologist at the Cleveland Clinic
- Sandra Park, One of the lead ACLU attorney’s on the Gene Patent case
- Ellen Matloff, Director of the Yale Cancer Center Genetic Counseling Program
- Kathleen Maxian, patient advocate & Co-Founder of the Western New York Ovarian Cancer Project
We invite you, on June 25th at 11am, to listen, learn and participate in this free one-hour interactive webinar: you’ll get to ask our panel of experts questions to understand what this decision means, moving forward, for you, for those you care about, and for people everywhere.